Small cell/neuroendocrine carcinoma may be a more common phenotype in advanced prostate cancer

被引:7
作者
Yashi, M [1 ]
Ishikawa, S [1 ]
Ochi, M [1 ]
Tokue, A [1 ]
机构
[1] Jichi Med Sch, Dept Urol, Minami Kawachi, Tochigi 3290498, Japan
关键词
D O I
10.1159/000065572
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:166 / 168
页数:3
相关论文
共 10 条
[1]  
Abrahamsson PA, 1999, PROSTATE, V39, P135, DOI 10.1002/(SICI)1097-0045(19990501)39:2<135::AID-PROS9>3.0.CO
[2]  
2-S
[3]   Oat-cell carcinoma of the prostate -: Diagnosis, prognosis and therapeutic implications [J].
Cubillana, PL ;
Barba, EM ;
Prieto, A ;
Pastor, GS ;
Sola, J ;
Nicolás, JA ;
Hernández, JAG ;
Gómez, G ;
Pertusa, PM ;
Albacete, MP ;
Bañón, V ;
Valdelvira, P ;
Guardiola, A ;
Castillo, D ;
Cao, E ;
Alonso, JD .
UROLOGIA INTERNATIONALIS, 2001, 67 (03) :209-212
[4]  
Ito T, 2001, ONCOL REP, V8, P1221
[5]   Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy [J].
Miyoshi, Y ;
Uemura, H ;
Kitami, K ;
Satomi, Y ;
Kubota, Y ;
Hosaka, M .
BJU INTERNATIONAL, 2001, 88 (09) :982-983
[6]   Small bioactive peptides and cell surface peptidases in androgen-independent prostate cancer [J].
Nelson, JB ;
Carducci, MA .
CANCER INVESTIGATION, 2000, 18 (01) :87-96
[7]   Progression of prostate cancer to neuroendocrine cell tumor [J].
Tanaka, M ;
Suzuki, Y ;
Takaoka, K ;
Suzuki, N ;
Murakami, S ;
Matsuzaki, O ;
Shimazaki, J .
INTERNATIONAL JOURNAL OF UROLOGY, 2001, 8 (08) :431-436
[8]  
TURBATHERRERA EA, 1988, ARCH PATHOL LAB MED, V112, P1100
[9]   Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients [J].
Yashi, M ;
Muraishi, O ;
Kobayashi, Y ;
Tokue, A ;
Nanjo, H .
PROSTATE, 2002, 51 (02) :84-97
[10]   Prostatic small-cell neuroendocrine carcinoma with disease progression monitored by measurement of serum progastrin-releasing peptide [J].
Yashi, M ;
Muraishi, O ;
Tokue, A .
BJU INTERNATIONAL, 2001, 88 (03) :306-308